Comerica Bank’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Comerica Bank’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.64M	Sell	47,233 -14,183	-23%	-$561K	0.01%	1192
2022 Q3	$2.88M	Sell	61,416 -860	-1%	-$55.5K	0.02%	807
2022 Q2	$4.61M	Sell	62,276 -1,155	-2%	-$84.4K	0.04%	563
2022 Q1	$5.16M	Sell	63,431 -486	-0.8%	-$41.1K	0.04%	574
2021 Q4	$5.51M	Buy	63,917 +1,109	+2%	+$106K	0.04%	522
2021 Q3	$5.62M	Sell	62,808 -7,957	-11%	-$720K	0.03%	621
2021 Q2	$6.23M	Buy	70,765 +9,672	+16%	+$817K	0.04%	578
2021 Q1	$5.41M	Buy	61,093 +13,872	+29%	+$1.05M	0.03%	697
2020 Q4	$3.59M	Buy	47,221 +925	+2%	+$57.7K	0.02%	911
2020 Q3	$2.69M	Buy	46,296 +5,054	+12%	+$301K	0.02%	923
2020 Q2	$2.58M	Buy	41,242 +3,344	+9%	+$180K	0.02%	911
2020 Q1	$1.91M	Buy	37,898 +99	+0.3%	+$5.79K	0.02%	941
2019 Q4	$2.36M	Buy	37,799 +555	+1%	+$29.8K	0.02%	1026
2019 Q3	$2M	Buy	37,244 +372	+1%	+$19.1K	0.02%	1106
2019 Q2	$1.75M	Sell	36,872 -4,256	-10%	-$198K	0.01%	1183
2019 Q1	$2.1M	Buy	41,128 +841	+2%	+$40.8K	0.02%	1091
2018 Q4	$2.03M	Buy	40,287 +737	+2%	+$34.2K	0.02%	1093
2018 Q3	$1.81M	Sell	39,550 -2,892	-7%	-$142K	0.01%	1219
2018 Q2	$2.07M	Sell	42,442 -2,125	-5%	-$88K	0.01%	1239
2018 Q1	$1.68M	Buy	44,567 +457	+1%	+$17.9K	0.01%	1329
2017 Q4	$1.77M	Buy	44,110 +320	+0.7%	+$15K	0.01%	1346
2017 Q3	$2.48M	Buy	43,790 +1,331	+3%	+$74.2K	0.02%	1076
2017 Q2	$2.42M	Buy	+42,459	New	+$2.21M	0.02%	1078

Other funds holding SYNH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Comerica Bank's SYNH Position: Q4 2022 in Review

Comerica Bank reduced its Syneos Health, Inc. Class A Common Stock (SYNH) stake by 23% in Q4 2022, selling an estimated $561K and leaving 47,233 shares worth $1.64M. The position accounts for 0.01% of the portfolio, ranked #1192.

Comerica Bank first reported a position in SYNH in Q2 2017 and has held it in 23 quarters since. The position peaked at $6.23M in Q2 2021. 305 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

Comerica Bank held 47,233 shares of Syneos Health, Inc. Class A Common Stock worth $1.64M as of Q4 2022.
Comerica Bank sold 14,183 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $561K.
Syneos Health, Inc. Class A Common Stock made up 0.01% of Comerica Bank's portfolio in Q4 2022, its #1192 holding.
Comerica Bank first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2017 and has held it in 23 quarters since.
Comerica Bank's Syneos Health, Inc. Class A Common Stock position peaked at $6.23M in Q2 2021.
305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Comerica Bank's 13F filing for Q4 2022, filed 26 Jan 2023.